Antibody Persistence 1-5 Years Following Vaccination With MenAfriVac in African Children Vaccinated at 12-23 Months of Age. (2015)
Attributed to:
Childhood tuberculosis: Integrating tools for improved diagnosis and vaccines
funded by
MRC
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.1093/cid/civ672
PubMed Identifier: 26553683
Publication URI: http://europepmc.org/abstract/MED/26553683
Type: Journal Article/Review
Volume: 61 Suppl 5
Parent Publication: Clinical infectious diseases : an official publication of the Infectious Diseases Society of America
Issue: Suppl 5
ISSN: 1058-4838